Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) and Prenetics Global (NASDAQ:PRE – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Singular Genomics Systems and Prenetics Global, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Singular Genomics Systems | 0 | 1 | 0 | 0 | 2.00 |
| Prenetics Global | 0 | 0 | 1 | 0 | 3.00 |
Singular Genomics Systems currently has a consensus target price of $6.50, indicating a potential downside of 67.52%. Prenetics Global has a consensus target price of $9.00, indicating a potential upside of 121.67%. Given Prenetics Global’s stronger consensus rating and higher possible upside, analysts clearly believe Prenetics Global is more favorable than Singular Genomics Systems.
Insider and Institutional Ownership
Volatility & Risk
Singular Genomics Systems has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.31, indicating that its share price is 131% less volatile than the S&P 500.
Profitability
This table compares Singular Genomics Systems and Prenetics Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Singular Genomics Systems | -3,237.89% | -57.87% | -37.90% |
| Prenetics Global | -191.73% | -16.45% | -13.34% |
Earnings and Valuation
This table compares Singular Genomics Systems and Prenetics Global”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Singular Genomics Systems | $2.91 million | 17.47 | -$94.82 million | ($35.11) | -0.57 |
| Prenetics Global | $25.56 million | 1.94 | -$62.72 million | ($3.99) | -1.02 |
Prenetics Global has higher revenue and earnings than Singular Genomics Systems. Prenetics Global is trading at a lower price-to-earnings ratio than Singular Genomics Systems, indicating that it is currently the more affordable of the two stocks.
Summary
Prenetics Global beats Singular Genomics Systems on 9 of the 14 factors compared between the two stocks.
About Singular Genomics Systems
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.
